Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT2 | Q96PD7 | 8/20 | 0.49 |
| ▸ | MC2R | Q01718 | 1/20 | 0.48 |
| ▸ | PIM1 | P11309 | 2/20 | 0.43 |
| ▸ | ACP1 | P24666 | 1/20 | 0.43 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.40 |
| ▸ | PDE1A | P54750 | 2/20 | 0.39 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.39 |
| ▸ | PDE1C | Q14123 | 2/20 | 0.39 |
| ▸ | PBK | Q96KB5 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31077879 | 0.84 | MC2R (0.58) | DGAT2MC2RACP1 | |
| SCHEMBL23201613 | 0.82 | DGAT2 (0.51) | DGAT2MC2RACP1ALDH1A1PBK | |
| SCHEMBL30090945 | 0.82 | MC2R (0.54) | MC2RNTRK1IRAK4 | |
| SCHEMBL30090944 | 0.82 | MC2R (0.54) | MC2RNTRK1IRAK4 | |
| SCHEMBL31162221 | 0.82 | MC2R (0.54) | MC2RNTRK1IRAK4 | |
| SCHEMBL31077853 | 0.77 | USP30 (0.59) | MC2RPARP1 | |
| SCHEMBL23201599 | 0.75 | PIM1 (0.63) | PIM1ALDH1A1IRAK4PARP1 | |
| SCHEMBL23201602 | 0.75 | IRAK4 (0.56) | MC2RNTRK1ALDH1A1IRAK4 | |
| Formic Acid SCHEMBL31078013 | 0.75 | MC2R (0.49) | DGAT2MC2RACP1NTRK1PDE1A | |
| SCHEMBL21700619 | 0.75 | MC2R (0.75) | DGAT2MC2RACP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024175925-A1 | MC2R MODULATOR COMPOUNDS | Omass Therapeutics Limited (GB) | 2024-08-29 | — | — | WO | disclosed |